Outcome of reoperation for thyroid cancer:clinical analysis of 147 cases
返回论文页
|更新时间:2023-12-18
|
Outcome of reoperation for thyroid cancer:clinical analysis of 147 cases
Journal of Chongqing Medical UniversityVol. 37, Issue 10, Pages: 904-906(2012)
作者机构:
重庆医科大学附属第一医院内分泌外科,重庆,400016
作者简介:
基金信息:
DOI:
CLC:
Published:2012,
扫 描 看 全 文
YU Feng, SU Xinliang. Outcome of reoperation for thyroid cancer:clinical analysis of 147 cases. [J]. Journal of Chongqing Medical University 37(10):904-906(2012)
DOI:
YU Feng, SU Xinliang. Outcome of reoperation for thyroid cancer:clinical analysis of 147 cases. [J]. Journal of Chongqing Medical University 37(10):904-906(2012)DOI:
Outcome of reoperation for thyroid cancer:clinical analysis of 147 cases
Objective:To analyze the cause of reoperation for differentiated thyroid carcinoma(DTC) and to explore the time and proper surgical patterns for the reoperation. Methods:Protocols of 147 patients undergoing reoperation for thyroid cancer from January 2002 to September 2009 were reviewed retrospectively with the study considering domestic and foreign literatures. The reoperation in-cluded total thyroidectomy for 66 cases,near-total thyroidectomy for 28 cases,subtotal thyroidectomy for 17 cases,unilateral lobecto-my for 1 case and palliactive mass excision for 17 cases. Central lymph node dissection or modified neck dissection for 116 cases were performed at the same time. Results:Pathological results after reoperation confirmed that the rate of residual carcinoma in thyroid tis-sue was 65.6%(82/125) and the rate of residual in lymph node was 62.9%(28/32). The rate of temporarily recurrent laryngeal nerve injury was 0.68%(1/147) and of temporary hypocalcaemia was 6.8%(10/147),without permanent laryngeal recurrent nerve hurt or hypocalcaemia. Conclusions:Inadequate initial operation,local recurrence and cervical lymph node metastasis of thyroid cancer need reoperation sundoubtedly. The optimal treatment is total thyroidectomy with central compartment lymph node dissection or modified neck dissection.
Therapy response and prognosis of different doses of 131I for low- and intermediate-risk differentiated thyroid carcinoma
Influence of thyroid stimulating hormone suppression therapy after differentiated thyroid cancer surgery on serum anti-mullerian hormone level in women of childbearing age
Related Author
Zhang Jing
Chen Chang
Yang Yi
Zhang Bin
Xing Ying
Liu Xiaoli
Sun Hui
Zhang Guang
Related Institution
Department of Nuclear Medicine,The First Affiliated Hospital of Soochow University
Department of Nuclear Medicine,Suzhou Science & Technology Town Hospital,Nanjing Medical University
Department of Endocrinology and Metabolism,Institute of Endocrinology,Liaoning Provincial Key Laboratory of Endocrine Diseases,The First Hospital of China Medical University
Department of Thyroid Surgery, China-Japan Union Hospital Affiliated to Jilin University,Jilin Provincial Key Laboratory of Surgical Translational Medicine